Searched for
US PENICILLIN
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Pharma exports fall to five-year low in March amid West Asia crisisIndia's pharma exports saw a sharp 23.17% fall in March. The West Asia war disrupted shipping routes and air transit hubs. This led to incr...
- Quote of the day by Howard Florey: ‘Great ideas often come from unexpected places; never underestimate…’Howard Florey, alongside his Oxford team, transformed Alexander Fleming's 1928 discovery into a life-saving drug. Their crucial work in iso...
- The penicillin war: India's journey from self-sufficiency to dependence on ChinaAfter India lost its dominance in making penicillin, a drought of three decades is coming to an end. The drug – which forms the base for a ...
- All it takes: 1% god's graceLook at how Alexander Fleming discovered penicillin. Upon returning from a vacation, Fleming checked on colonies of staphylococcus bacteria...
- From anaesthesia to penicillin: Drugs that changed the world, for better or worseIt's a good reminder that today's wonder drug may be tomorrow's problem drug.
- Shortage of important form of penicillin affecting 39 countries, including India: AMFIn Brazil, the shortage of penicillin coincided with a syphilis outbreak that, as a result, could not be brought under control. Between 201...
- Penicillin allergy may increase risk of infectionsNew York, Oct 9 (IANS) Surgical patients with recorded penicillin allergy may be at 50 per cent higher risk of developing infections, new r...
- Need no monopoly in healthcare in India: YK Hamied, Chairman, CiplaThe pharma industry is not like cement or sugar where you go on making it year in year out and there is no change. Here the older drugs die...
- Guru Madhavan's Applied Minds: Engineering solutions that make a big differenceGuru Madhavan's book, Applied Minds, is full of such stories of engineers who worked against odds to come up with solutions that made a big...
- Dr Reddy's launches Amoxicillin tablets, capsules in US marketDr Reddy's today announced the launch of antibiotic Amoxicillin tablets, capsules and oral suspension.
- Orchid Chemicals's facility sale more of a desperate attempt to improve the balance sheetOrchid Chemicals sale of its penicillin and penem API facility to US-based Hospira is more of a desperate attempt to cut down debt rather t...
- Aurobindo Pharma forms JV with Russian Ojsc Diod for generic productsAurobindo Pharma on Wednesday said it has formed an equal joint venture with Russian healthcare equipment company Ojsc Diod.
- Dr Reddy's acquires GSK's US penicillin facilityDr Reddy's Laboratories has acquired GlaxoSmithKline's US penicillin manufacturing facility and the rights to the Augmentin and Amoxil bran...
- Dr Reddy’s buys GSK’s oral penicillin facility in USDr Reddy’s Laboratories, one of the country’s biggest drug firms, has bought GlaxoSmithKline’s oral penicillin facility and products in the...
- Strides Acrolab receives US FDA approvalThe Rs 1000 crore generic pharma company has received US FDA inspection approval status for its steriles injectable complex at Bangalore.
- Arch Pharma plans to raise Rs 100 crore private equityArch Pharmalabs, a Rs 246-crore Mumbai-based active pharmaceutical ingredient (API) manufacturer, is close to raising Rs 100 crore through ...
- Arch Pharmalabs to raise Rs 100 cr via pvt placementArch Pharmalabs, a Rs 246-crore Mumbai-based active pharmaceutical ingredient (API) maker, is close to raising Rs 100 crore through private...
Load More
